Initial In Vivo Evaluation of a Novel Amikacin-Deoxycholate Hydrophobic Salt Delivers New Insights on Amikacin Partition in Blood and Tissues
In this study, an initial in vivo evaluation of a new amikacin-deoxycholate hydrophobic salt aimed at potentiating amikacin action against hard-to-treat lung infections was undertaken by quantifying, for the first time, amikacin in whole blood. Pharmacokinetic evaluation after intranasal administrat...
Saved in:
Main Authors: | Styliani Xiroudaki (Author), Federica Ianni (Author), Samuele Sabbatini (Author), Elena Roselletti (Author), Claudia Monari (Author), Roccaldo Sardella (Author), Anna Vecchiarelli (Author), Stefano Giovagnoli (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluating the efficacy of inhaled amikacin as an adjunct to intravenous combination therapy (ceftazidime and amikacin) in pediatric cystic fibrosis pulmonary exacerbation
by: Amin Rakhshan, et al.
Published: (2023) -
Reagent-free determination of amikacin content in amikacin sulfate injections by FTIR derivative spectroscopy in a continuous flow system
by: José F. Ovalles, et al.
Published: (2014) -
The Direction of the Antibacterial Effect of Rutin Hydrate and Amikacin
by: Maria Miklasińska-Majdanik, et al.
Published: (2023) -
Carvacrol attenuates amikacin-induced nephrotoxicity in the rats
by: Cemil Çolak, et al.
Published: (2024) -
Cystatin C level and amikacin use in neonatal sepsis
by: Putu Diah Pratiwi, et al.
Published: (2019)